Barcelona Clinical Coordinating Center (BCCC), the non-profit contract research organization responsible for clinical coordination and patient recruitment, announces the completion of enrollment in the OPAL study, a first-in-human and pivotal clinical study evaluating the novel embolic liquid system Amber, sponsored by iVascular, a company developing innovative advanced medical devices and therapies for the treatment of… Read more »

The European Commission has announced the opening of the new Joint Scientific Consultations (JSCs) periods under EU Health Technology Assessment (HTA) Regulation (Regulation (EU) 2021/2282) (sourced link). JSCs enable health technology developers to obtain coordinated, EU-level feedback while planning clinical studies, focused on the evidence needs for a potential future Joint Clinical Assessment (JCA). JSCs… Read more »

The EIC Access + is a program that provides financial support to EIC beneficiaries to access expert business services and support their growth.